PHARMACOGENETIC ASSOCIATION OF beta 1-ADRENERGIC RECEPTOR SER49GLY POLYMORPHISM WITH OUTCOMES IN THE SECONDARY PREVENTION OF SMALL SUBCORTICAL STROKES (SPS3) TRIAL.

O. Magvanjav,C. W. McDonough, Y. Gong, L. A. McClure, R. L. Talbert, R. B. Horenstein,B. D. Mitchell,A. R. Shuldiner, O. R. Benavente,J. A. Johnson

CLINICAL PHARMACOLOGY & THERAPEUTICS(2016)

引用 0|浏览0
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要